Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
65.40    0.00 (0.00%)
Bid:
65.20
Ask:
70.00
Spread: 4.80 (7.362%)
Market Cap: £88.27m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Interim Management Statement

13 Feb 2008 07:00

Trifast PLC13 February 2008 TRIFAST PLC ('Trifast' or 'the Company' or 'the Group') INTERIM MANAGEMENT STATEMENT 13 February 2008 Trifast, a worldwide manufacturer and distributor of industrial fasteners andcomponents, today announces its interim management statement for the thirdquarter to 31 December 2007. Group operating profit for the first two months of the period indicated thatmarket expectations for the year as a whole would be met. However, December'sresult fell below that expected due to the longer than anticipated shutdownperiod at OEMs in Europe resulting in fewer invoicing days. The Board is pleasedto report however, that the indications for January trading are ahead of prioryear results and in line with expectations for the month. The December result has had an inevitable impact on trading for the year as awhole. Consequently the Board believes that, subject to the performance ofTrifast's worldwide markets in the remainder of the current year and based oncurrent sales performance, the profit before tax (before restructuring costs,intangible amortisation and IFRS2 charge) for the full year ending 31 March 2008will be broadly in line with that reported for the year ended 31 March 2007 of£8.8 million. This trading performance would reflect an operating margin of7.9%, a 7% improvement on the March 2007 figure of 7.4%, a credible step towardsachieving the Board's target of 10% net operating profit (before restructuringcosts, intangible amortisation and IFRS2 charge). During the period the Company continued its recruitment drive for quality salespeople and our restructured sales team is now nearing completion. It will have apositive impact, and already we have seen the number of new enquiries frompotential customers increase significantly. The Board remains focused on the Trifast strategy for long term profitable salesgrowth with the continued emphasis on the quality of business won. The fullbenefit is yet to be realised. The key elements of this strategy are: - Targeting growth market sectors;- Developing market leading customer service plans;- Manufacturing high quality products and- Providing full technical and engineering support. Furthermore the management team have implemented a number of initiatives,including: - Driving into new market areas including Poland and other areas of Central Europe;- Focused sales team in Asia to drive into local markets;- Improving percentage of total fastenings sales within the existing customer base;- Master Distributor Programme gaining momentum in the USA and- Developing our business in India. - ENDS - Enquiries Trifast Group plc Tel: 01825 747 366Steve Auld, Chief Executive OfficerStuart Lawson, Chief Financial Officer Smithfield ConsultantsReg Hoare / Will Swan Tel: 020 7360 4900 Fairfax I.S. plcSteve Roberts / Jeremy Porter Tel: 020 7598 5368 For more information please visit www.trifast.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Nov 20243:09 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSHALF-YEARLY FINANCIAL REPORT
22nd Oct 20247:00 amRNSTrading update and Notice of Half-year results
12th Sep 20244:21 pmRNSDirector/PDMR Shareholding
10th Sep 20244:48 pmRNSResult of AGM
10th Sep 20247:01 amRNSAGM Statement
10th Sep 20247:00 amRNSAppointment of CFO
27th Aug 20249:21 amRNSProposed new Directors Remuneration Policy
21st Aug 20249:32 amRNSDirector/PDMR Shareholding
15th Aug 202411:40 amRNSHolding(s) in Company
6th Aug 20243:49 pmRNSPurchase of shares
31st Jul 20244:00 pmRNSAvailability of Annual Report & Notice of Meeting
29th Jul 20247:00 amRNSAnnual Results - 31 March 2024 - Annual Report
23rd Jul 20247:00 amRNSFY24 annual results - date confirmation
2nd Jul 20244:43 pmRNSFY24 results publication–revision of release date
11th Jun 20249:24 amRNSAnnual results presentations
25th Apr 20247:00 amRNSTrading update & Notice of Annual results
15th Apr 20242:11 pmRNSDirector/PDMR Shareholding
15th Apr 20241:07 pmRNSDirector/PDMR Shareholding
4th Apr 202410:40 amRNSBlock listing Interim Review
21st Mar 20247:00 amRNSDirector/PDMR Shareholding - Purchase of shares
13th Mar 20242:30 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSAppointment & retirement of non-executive director
22nd Feb 20247:00 amRNSDirectorate Change
9th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 202410:09 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20249:33 amRNSHolding(s) in Company
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 202411:23 amRNSDirector/PDMR Shareholding
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSTrading Update
3rd Jan 20245:50 pmRNSTotal Voting Rights
21st Dec 20234:24 pmRNSHolding(s) in Company
21st Dec 20234:18 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSNon executive director retirement update
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSPDMR - Performance conditions for LTIP award
24th Nov 20232:34 pmRNSDirector/PDMR shareholding - Purchase of shares
21st Nov 20237:00 amRNSHalf-year Report - six months to 30 September 2023
24th Oct 20237:00 amRNSHalf year trading update and notice of results
19th Oct 20237:00 amRNSNon-executive Director appointment
12th Oct 20237:00 amRNSDirectorate retirement
3rd Oct 20234:16 pmRNSBlock listing Interim Review
25th Sep 20233:49 pmRNSHolding(s) in Company
19th Sep 20234:45 pmRNSPDMR Save As You Earn Plan grant of Option
15th Sep 20233:05 pmRNSResult of AGM
15th Sep 20239:15 amRNSCEO appointment
14th Sep 20234:48 pmRNSDirectorate Change
29th Aug 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.